Nawar Al Saieg, Michael J Luzar. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antirheumatic Agents/adverse effectsBrain/pathologyEtanerceptFemaleGlucocorticoids/therapeutic useHumansImmunoglobulin G/adverse effectsMagnetic Resonance ImagingMethylprednisolone/therapeutic useMiddle AgedMultiple Sclerosis/chemically inducedMultiple Sclerosis/drug therapyMultiple Sclerosis/pathologyMyelitis, Transverse/chemically inducedMyelitis, Transverse/drug therapyMyelitis, Transverse/pathologyReceptors, Tumor Necrosis FactorSpinal Cord/pathologyTreatment Outcome
Substances: See more » Antirheumatic AgentsGlucocorticoidsImmunoglobulin GReceptors, Tumor Necrosis FactorEtanerceptMethylprednisolone
Year: 2006 PMID: 16755671
Source DB: PubMed Journal: J Rheumatol ISSN: 0315-162X Impact factor: 4.666